{
    "bipacksedel": {},
    "produktresume": {},
    "fass_text": {},
    "bilder_och_delbarhet": {},
    "miljöinformation": {
        "env-effect": "Basiliximab Miljörisk: Användning av aminosyror, proteiner och peptider bedöms inte medföra någon miljöpåverkan. Läs mer Detaljerad miljöinformation The use of amino acids/peptides/proteins has been considered to result in an insignificant environmental impact. According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment. It is expected that any administered monoclonal antibody is completely metabolized and absorbed in the body. Any medicinal product that reaches water streams via spills during an application or after disposal of the unused drug, is expected to be very rapidly degraded and mineralized to CO2 by microbial activity. References EMEA/CHMP/SWP/4447/00 corr 2. Guideline on the environmental risk assessment of medicinal products for human use. London, 01 June 2006. Environmental classification of pharmaceuticals at (www.fass.se) -Guidance for pharmaceutical companies 2012"
    },
    "skyddsinfo": {},
    "product_name": {
        "product_name": "Simulect®, Pulver och vätska till injektions-/infusionsvätska, lösning 10 mg"
    }
}